CONMED Corporation (NYSE:CNMD) Q4 2022 Earnings Call Transcript

Page 9 of 9

And we’ll allow them to do that versus on a phone call. But we’re excited about academy. We’ve got a lot going into this year and there’s a couple other really big trade shows in 2023. is going to be in the States this year, that’s typically every other year. There’s a great show in September that we go to OSAT and those are great trade shows for CONMED’s orthopedics business. On the general surgery side, there’s lesser big shows, I mean, AORN is a very big show and we’ve got a wonderful portfolio there. And then our AET business goes to some smaller localized shows, but has a couple of big shows. And we have some nice products there. One that I came out of the sales meeting really encouraged by and the sales force, very encouraged by. So we’re excited about the organic portfolio.

As much as we are in the inorganic portfolio and just got to get in front of our customers.

Matthew Mishan: Thanks, Todd.

Operator: And thank you. And I’m showing no further questions. I would now like to turn the call back over to Curt Hartman for closing remarks.

Curt Hartman: All right. Thank you, Justin, and thank you everybody for being with us today. And we look forward to speaking with you during our next earnings call and wish you all a good evening. Thank you.

Operator: This concludes today’s conference call. Thank you for participating. You may now disconnect.

Follow Conmed Corp (NASDAQ:CNMD)

Page 9 of 9